NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

解酸劑的全球市場:未來預測 (2027年),各劑型·各類藥物·各流通管道·各地區的分析,新型冠狀病毒感染疾病 (COVID-19)的影響

Antacid Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Dosage Form ; Drug Class ; Distribution Channel and Geography

出版商 The Insight Partners 商品編碼 983302
出版日期 內容資訊 英文 182 Pages
訂單完成後即時交付
價格
解酸劑的全球市場:未來預測 (2027年),各劑型·各類藥物·各流通管道·各地區的分析,新型冠狀病毒感染疾病 (COVID-19)的影響 Antacid Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Dosage Form ; Drug Class ; Distribution Channel and Geography
出版日期: 2020年11月30日內容資訊: 英文 182 Pages
簡介

全球解酸劑的市場規模預測將從2019年的85億4797萬美元,到2027年達到是116億6683萬美元的規模,並以4.0%的年複合成長率增長。解酸劑市場主要的促進因素有GERD(胃食管反流病)和肥胖症的患病率上升。另一方面,低收入國家與胃腸道疾病有關的意識低下也會阻礙市場的增長。

本報告提供全球解酸劑的市場相關分析,彙整市場基本結構和背景情況 (主要促進·阻礙因素等),市場規模趨勢預測 (今後9年份),各劑型·各類藥物·各流通管道·各地區的詳細趨勢,主要企業的簡介與策略展開情形,隨著近來新型冠狀病毒感染疾病 (COVID-19) 的影響等資訊,為您概述為以下內容。

目錄

第1章 簡介

第2章 解酸劑市場:分析概要

第3章 分析方法

第4章 解酸劑市場:市場環境

  • 概要
  • PEST分析
  • 專家的見解

第5章 全球解酸劑市場:市場動態

  • 推動市場要素
  • 阻礙市場要素
  • 市場機會
  • 今後趨勢
  • 影響度分析

第6章 解酸劑市場:全球市場分析

  • 市場收益額的預測與分析
  • 市場規模的預測與分析:各地區
  • 主要企業的市場定位

第7章 解酸劑市場:劑型別分析

  • 概要
  • 解酸劑市場:各劑型佔有率 (2019年,到2027年)
  • 錠劑
  • 液體
  • 其他

第8章 解酸劑市場:各類藥物分析

  • 概要
  • 解酸劑市場:各類藥物佔有率 (2019年,到2027年)
  • 質子幫浦抑制劑
  • H2拮抗劑
  • 酸中和劑

第9章 解酸劑市場:各流通管道分析

  • 概要
  • 解酸劑市場:各流通管道佔有率 (2019年,到2027年)
  • 醫院藥局
  • 零售藥局
  • 線上藥局

第10章 解酸劑市場:各地區的分析

  • 北美:解酸劑市場
  • 歐洲:解酸劑市場
  • 亞太地區:解酸劑市場
  • 中東·非洲:解酸劑市場
  • 中南美:解酸劑市場

第11章 全球解酸劑市場上新型冠狀病毒感染疾病 (COVID-19) 感染擴大的影響

  • 北美:COVID-19感染擴大的影響度的評估
  • 歐洲:COVID-19感染擴大的影響度的評估
  • 亞太地區:COVID-19感染擴大的影響度的評估
  • 其他的國家 (RoW):COVID-19感染擴大的影響度的評估

第12章 解酸劑市場:產業形勢

  • 概要
  • 各企業發展的成長策略
  • 有機的發展
  • 無機的發展

第13章 企業簡介

  • Bayer AG
  • GlaxoSmithKline plc.
  • Takeda Pharmaceutical Company Limited
  • Sun Pharmaceutical Industries Ltd
  • Sanofi
  • Boehringer Ingelheim International GmbH
  • Dr. Reddy's Laboratories
  • Pfizer Inc.
  • Reckitt Benckiser Group Plc
  • Procter & Gamble

第14章 附錄

目錄
Product Code: TIPRE00016359

The global antacid market is expected to reach US$ 11,666.83 million in 2027 from US$ 8,547.97 million in 2019. The market is estimated to grow with a CAGR of 4.0% from 2020-2027. The growth of the antacid market is mainly attributed to the globally rising prevalence of GERD and increasing prevalence of obesity. However, low awareness associated with gastrointestinal disorders in low-income economies is restricting the market growth.

Obesity is a major risk factor for the development of GERD. The excess of belly fat causes pressure on the stomach, and the development of a hiatal hernia leads to backflow of acid. Also, increased relaxation of lower esophageal sphincter (LES) in obese people causes higher acid reflux.

As per the study 'The Association Between Obesity and GERD: A Review of the Epidemiological Evidence' overweight or people with high BMI (25-30 kg/m²) or people who are obese with BMI >30 kg/m² often suffer from acidity or GERD.

As per the WHO, over 1.9 billion adults were overweight in 2016. Of which over 650 million were obese. Furthermore, as per the Statistics on Obesity, Physical Activity and Diet, England, 2020, in England, the majority of adults were overweight or obese; 67% of men and 60% of women. Additionally, as per the CDC National Center for Health Statistics (NCHS), the prevalence of obesity was 42.4% in the US in 2017~2018. Similarly, obesity is a major health concern in China. According to the study database by researchers at Chinese National Center for Disease Control and Prevention, Beijing, the prevalence of obesity increased over three times from 2004 to 2014 across China, whereas the rate of abdominal obesity increased by more than 50%. Thus, growing obesity favors the growth of the market.

Based on dosage form, the antacid market is segmented into tablet, liquid, and others. In 2019, the tablet segment held the largest share of the market. The liquid segment is expected to grow at the fastest rate during the coming year. Based on drug class, the market was segmented into proton pump inhibitors, H2 antagonist, and acid neutralizers. In 2019, The proton pump inhibitors segment held the largest share of the market in 2019, and the same segment is anticipated to register the highest CAGR in the market during the forecast period. Based on distribution channel, the antacid market is segmented into hospital pharmacy, retail pharmacy, and online pharmacy. The retail pharmacy segment held the largest share of the market in 2019.

World Health Organization, National Health Service, Centers for Disease Control and Prevention, Canadian Digestive Health Foundation, and Canadian Association of Gastroenterology, along with company websites, are the major primary and secondary sources cited while preparing this report.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the antacid market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global antacid market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Antacid Market - By Dosage Form
    • 1.3.2 Antacid Market - By Drug Class
    • 1.3.3 Antacid Market - By Distribution Channel
    • 1.3.4 Global Antacid Market - By Geography

2. Antacid Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Global Antacids- Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America - PEST Analysis
    • 4.2.2 Europe - PEST Analysis
    • 4.2.3 Asia Pacific - PEST Analysis
    • 4.2.4 Middle East and Africa (MEA) - PEST Analysis
    • 4.2.5 South and Central America (SCAM) - PEST Analysis
  • 4.3 Expert Opinions

5. Antacid Market- Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rise in Prevalence of Gastroesophageal Reflux Disease (GERD)
    • 5.1.2 Increase in Prevalence of Obesity
  • 5.2 Market Restraints
    • 5.2.1 Low Awareness Associated with Gastrointestinal Disorders in Low-Income Economies
  • 5.3 Market Opportunities
    • 5.3.1 Increasing Research Activities and Research Funds on GI Disorders
  • 5.4 Future Trends
    • 5.4.1 Development and Launch of Innovative Products
  • 5.5 Impact Analysis

6. Antacid Market - Global Analysis

  • 6.1 Global Antacid Market Revenue Forecast And Analysis
  • 6.2 Global Antacid Market, By Geography - Forecast And Analysis
  • 6.3 Market Positioning of Key Players

7. Antacid Market Analysis - By Dosage Form

  • 7.1 Overview
  • 7.2 Antacid Market Revenue Share, by Dosage Form (2019 and 2027)
  • 7.3 Tablet
    • 7.3.1 Overview
    • 7.3.2 Tablet: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.4 Liquid
    • 7.4.1 Overview
    • 7.4.2 Liquid: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.5 Others
    • 7.5.1 Overview
    • 7.5.2 Others: Antacid Market - Revenue and Forecast to 2027 (US$ Million)

8. Antacid Market Analysis - By Drug Class

  • 8.1 Overview
  • 8.2 Antacid Market Revenue Share, by Drug Class (2019 and 2027)
  • 8.3 Proton Pump Inhibitors
    • 8.3.1 Overview
    • 8.3.2 Proton Pump Inhibitors: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.4 H2 Antagonist
    • 8.4.1 Overview
    • 8.4.2 H2 Antagonist: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.5 Acid Neutralizers
    • 8.5.1 Overview
    • 8.5.2 Acid Neutralizers: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
    • 8.5.3 Magaldrate
      • 8.5.3.1 Overview
      • 8.5.3.2 Magaldrate: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
    • 8.5.4 Sucralfate
      • 8.5.4.1 Overview
      • 8.5.4.2 Sucralfate: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
    • 8.5.5 Others
      • 8.5.5.1 Overview
      • 8.5.5.2 Others: Antacid Market - Revenue and Forecast to 2027 (US$ Million)

9. Antacid Market Analysis - By Distribution Channel

  • 9.1 Overview
  • 9.2 Antacid Market Share, by Distribution Channel, 2019 and 2027, (%)
  • 9.3 Hospital Pharmacy
    • 9.3.1 Overview
    • 9.3.2 Hospital Pharmacy: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.4 Retail Pharmacy
    • 9.4.1 Overview
    • 9.4.2 Retail Pharmacy: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.5 Online Pharmacy
    • 9.5.1 Overview
    • 9.5.2 Online Pharmacy: Antacid Market - Revenue and Forecast to 2027 (US$ Million)

10. Antacid Market - Geographic Analysis

  • 10.1 North America: Antacid Market
    • 10.1.1 Overview
    • 10.1.2 North America: Antacid Market - Revenue and Forecast to 2027 (USD Million)
    • 10.1.3 North America: Antacid Market, by Dosage Form, 2018-2027 (USD Million)
    • 10.1.4 North America: Antacid Market, by Drug Class, 2018-2027 (USD Million)
      • 10.1.4.1 North America: Acid Neutralizers Market, by Type, 2018-2027 (USD Million)
    • 10.1.5 North America: Antacid Market, by Distribution Channel, 2018-2027 (USD Million)
    • 10.1.6 North America: Antacid Market, by Country, 2019 & 2027 (%)
    • 10.1.7 US: Antacid Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.1 US: Antacid Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.2 US: Antacid Market, by Dosage Form, 2018-2027 (USD Million)
      • 10.1.7.3 US: Antacid Market, by Drug Class 2018-2027 (USD Million)
        • 10.1.7.3.1 US: Acid Neutralizers Market, by Type 2018-2027 (USD Million)
      • 10.1.7.4 US: Antacid Market, by Distribution Channel, 2018-2027 (USD Million)
    • 10.1.8 Canada: Antacid Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.1 Canada: Antacid Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.2 Canada: Antacid Market, by Dosage Form, 2018-2027 (USD Million)
      • 10.1.8.3 Canada: Antacid Market, by Drug Class 2018-2027 (USD Million)
        • 10.1.8.3.1 Canada: Acid Neutralizers Market, by Type 2018-2027 (USD Million)
      • 10.1.8.4 Canada: Antacid Market, by Distribution Channel, 2018-2027 (USD Million)
    • 10.1.9 Mexico: Antacid Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.1 Mexico: Antacid Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.2 Mexico: Antacid Market, by Dosage Form, 2018-2027 (USD Million)
      • 10.1.9.3 Mexico: Antacid Market, by Drug Class 2018-2027 (USD Million)
        • 10.1.9.3.1 Mexico: Acid Neutralizers Market, by Type 2018-2027 (USD Million)
      • 10.1.9.4 Mexico: Antacid Market, by Distribution Channel, 2018-2027 (USD Million)
  • 10.2 Europe: Antacid Market
    • 10.2.1 Overview
    • 10.2.2 Europe: Antacid Market - Revenue and Forecast to 2027 (USD Million)
    • 10.2.3 Europe: Antacid Market, by Dosage Form, 2018-2027 (USD Million)
    • 10.2.4 Europe: Antacid Market, by Drug Class 2018-2027 (USD Million)
      • 10.2.4.1 Europe: Acid Neutralizers Market, by Type 2018-2027 (USD Million)
    • 10.2.5 Europe: Antacid Market, by Distribution Channel, 2018-2027 (USD Million)
    • 10.2.6 Europe: Antacid Market, by Country, 2019 & 2027 (%)
    • 10.2.7 Germany: Antacid Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.7.1 Germany: Antacid Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.7.2 Germany: Antacid Market, by Dosage Form, 2018-2027 (USD Million)
      • 10.2.7.3 Germany: Antacid Market, by Drug Class 2018-2027 (USD Million)
        • 10.2.7.3.1 Germany: Acid Neutralizers Market, by Type 2018-2027 (USD Million)
      • 10.2.7.4 Germany: Antacid Market, by Distribution Channel, 2018-2027 (USD Million)
    • 10.2.8 UK: Antacid Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.8.1 UK: Antacid Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.8.2 UK: Antacid Market, by Dosage Form, 2018-2027 (USD Million)
      • 10.2.8.3 UK: Antacid Market, by Drug Class 2018-2027 (USD Million)
        • 10.2.8.3.1 UK: Acid Neutralizers Market, by Type 2018-2027 (USD Million)
      • 10.2.8.4 UK: Antacid Market, by Distribution Channel, 2018-2027 (USD Million)
    • 10.2.9 France: Antacid Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.9.1 France: Antacid Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.9.2 France: Antacid Market, by Dosage Form, 2018-2027 (USD Million)
      • 10.2.9.3 France: Antacid Market, by Drug Class 2018-2027 (USD Million)
        • 10.2.9.3.1 France: Acid Neutralizers Market, by Type 2018-2027 (USD Million)
      • 10.2.9.4 France: Antacid Market, by Distribution Channel, 2018-2027 (USD Million)
    • 10.2.10 Spain: Antacid Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.10.1 Spain: Antacid Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.10.2 Spain: Antacid Market, by Dosage Form, 2018-2027 (USD Million)
      • 10.2.10.3 Spain: Antacid Market, by Drug Class 2018-2027 (USD Million)
        • 10.2.10.3.1 Spain: Acid Neutralizers Market, by Type 2018-2027 (USD Million)
      • 10.2.10.4 Spain: Antacid Market, by Distribution Channel, 2018-2027 (USD Million)
    • 10.2.11 Italy: Antacid Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.11.1 Italy: Antacid Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.11.2 Italy: Antacid Market, by Dosage Form, 2018-2027 (USD Million)
      • 10.2.11.3 Italy: Antacid Market, by Drug Class 2018-2027 (USD Million)
        • 10.2.11.3.1 Italy: Acid Neutralizers Market, by Type 2018-2027 (USD Million)
      • 10.2.11.4 Italy: Antacid Market, by Distribution Channel, 2018-2027 (USD Million)
    • 10.2.12 Rest of Europe: Antacid Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.12.1 Rest of Europe: Antacid Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.12.2 Rest of Europe: Antacid Market, by Dosage Form, 2018-2027 (USD Million)
      • 10.2.12.3 Rest of Europe: Antacid Market, by Drug Class 2018-2027 (USD Million)
        • 10.2.12.3.1 Rest of Europe: Acid Neutralizers Market, by Type 2018-2027 (USD Million)
      • 10.2.12.4 Rest of Europe: Antacid Market, by Distribution Channel, 2018-2027 (USD Million)
  • 10.3 Asia-Pacific: Antacid Market
    • 10.3.1 Overview
    • 10.3.2 Asia-Pacific: Antacid Market,- Revenue and Forecast to 2027 (USD Million)
    • 10.3.3 Asia-Pacific: Antacid Market, by Dosage Form- Revenue and Forecast to 2027 (USD Million)
    • 10.3.4 Asia-Pacific: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
      • 10.3.4.1 Asia-Pacific: Antacid Market, by Acid Neutralizers - Revenue and Forecast to 2027 (USD Million)
    • 10.3.5 Asia-Pacific: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.3.6 Asia-Pacific: Antacid Market, by Country, 2019 & 2027 (%)
    • 10.3.7 China: Antacid Market, - Revenue and Forecast to 2027 (USD Million)
      • 10.3.7.1 China: Antacid Market, - Revenue and Forecast to 2027 (USD Million)
      • 10.3.7.2 China: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
      • 10.3.7.3 China: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
        • 10.3.7.3.1 China: Antacid Market, by Acid Neutralizers - Revenue and Forecast to 2027 (USD Million)
      • 10.3.7.4 China: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.3.8 Japan: Antacid Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.8.1 Japan: Antacid Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.8.2 Japan: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
      • 10.3.8.3 Japan: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
        • 10.3.8.3.1 Japan: Antacid Market, by Acid Neutralizers - Revenue and Forecast to 2027 (USD Million)
      • 10.3.8.4 Japan: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.3.9 India: Antacid Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.9.1 India: Antacid Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.9.2 India: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
      • 10.3.9.3 India: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
      • 10.3.9.4 India: Antacid Market, by Acid Neutralizers - Revenue and Forecast to 2027 (USD Million)
      • 10.3.9.5 India: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.3.10 South Korea: Antacid Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.10.1 South Korea: Antacid Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.10.2 South Korea: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
      • 10.3.10.3 South Korea: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
        • 10.3.10.3.1 South Korea: Antacid Market, by Acid Neutralizers - Revenue and Forecast to 2027 (USD Million)
      • 10.3.10.4 South Korea: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.3.11 Australia: Antacid Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.11.1 Australia: Antacid Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.11.2 Australia: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
      • 10.3.11.3 Australia: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
        • 10.3.11.3.1 Australia: Antacid Market, by Acid Neutralizers - Revenue and Forecast to 2027 (USD Million)
      • 10.3.11.4 Australia: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.3.12 Rest of Asia Pacific: Antacid Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.12.1 Rest of Asia Pacific: Antacid Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.12.2 Rest of Asia Pacific: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
      • 10.3.12.3 Rest of Asia Pacific: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
      • 10.3.12.4 Rest of Asia Pacific: Antacid Market, by Acid Neutralizers - Revenue and Forecast to 2027 (USD Million)
      • 10.3.12.5 Rest of Asia Pacific: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • 10.4 Middle East & Africa: Antacid Market
    • 10.4.1 Overview
    • 10.4.2 Middle East & Africa: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
    • 10.4.3 Middle East & Africa: Antacid Market, by Dosage Form- Revenue and Forecast to 2027 (USD Million)
    • 10.4.4 Middle East & Africa: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
      • 10.4.4.1 Middle East & Africa: Antacid Market, by Acid Neutralizers - Revenue and Forecast to 2027 (USD Million)
    • 10.4.5 Middle East & Africa: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.4.6 Middle East & Africa: Antacid Market, by Country, 2019 & 2027 (%)
    • 10.4.7 Saudi Arabia: Antacid Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.7.1 Saudi Arabia: Antacid Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.7.2 Saudi Arabia: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
      • 10.4.7.3 Saudi Arabia: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
        • 10.4.7.3.1 Saudi Arabia: Antacid Market, by Acid Neutralizers - Revenue and Forecast to 2027 (USD Million)
      • 10.4.7.4 Saudi Arabia: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.4.8 UAE: Antacid Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.8.1 UAE: Antacid Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.8.2 UAE: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
      • 10.4.8.3 UAE: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
      • 10.4.8.4 UAE: Antacid Market, by Acid Neutralizers - Revenue and Forecast to 2027 (USD Million)
      • 10.4.8.5 UAE: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.4.9 South Africa: Antacid Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.9.1 South Africa: Antacid Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.9.2 South Africa: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
      • 10.4.9.3 South Africa: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
      • 10.4.9.4 Asia-Pacific: Antacid Market, by Acid Neutralizers - Revenue and Forecast to 2027 (USD Million)
      • 10.4.9.5 South Africa: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.4.10 Rest of Middle East and Africa: Antacid Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.10.1 Rest of Middle East and Africa: Antacid Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.10.2 Rest of Middle East and Africa: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
      • 10.4.10.3 Rest of Middle East and Africa: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
      • 10.4.10.4 Asia-Pacific: Antacid Market, by Acid Neutralizers - Revenue and Forecast to 2027 (USD Million)
      • 10.4.10.5 Rest of Middle East and Africa: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • 10.5 South and Central America: Antacid Market
    • 10.5.1 Overview
    • 10.5.2 South and Central America: Antacid Market - Revenue and Forecast to 2027 (USD Million)
    • 10.5.3 South and Central America: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
    • 10.5.4 South and Central America: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
      • 10.5.4.1 South and Central America: Acid Neutralizers Market, by Type - Revenue and Forecast to 2027 (USD Million)
    • 10.5.5 South and Central America: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.5.6 South and Central America: Antacid Market, by Country, 2019 & 2027 (%)
    • 10.5.7 Brazil: Antacid Market - Revenue and Forecast to 2027 (USD Million)
      • 10.5.7.1 Brazil: Antacid Market - Revenue and Forecast to 2027 (USD Million)
      • 10.5.7.2 Brazil: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
      • 10.5.7.3 Brazil: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
        • 10.5.7.3.1 Brazil: Acid Neutralizers Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.5.7.4 Brazil: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.5.8 Argentina: Antacid Market - Revenue and Forecast to 2027 (USD Million)
      • 10.5.8.1 Argentina: Antacid Market - Revenue and Forecast to 2027 (USD Million)
      • 10.5.8.2 Argentina: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
      • 10.5.8.3 Argentina: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
        • 10.5.8.3.1 Argentina: Acid Neutralizers Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.5.8.4 Argentina: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.5.9 Rest of South and Central America: Antacid Market - Revenue and Forecast to 2027 (USD Million)
      • 10.5.9.1 Rest of South and Central America: Antacid Market - Revenue and Forecast to 2027 (USD Million)
      • 10.5.9.2 Rest of South and Central America: Antacid Market, by Therapeutic - Revenue and Forecast to 2027 (USD Million)
      • 10.5.9.3 Rest of South and Central America: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
        • 10.5.9.3.1 Rest of South and Central America: Acid Neutralizers Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.5.9.4 Rest of South and Central America: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)

11. Impact of COVID-19 Pandemic on Global Antacid Market

  • 11.1 North America: Impact Assessment of COVID-19 Pandemic
  • 11.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
  • 11.4 Rest of the World: Impact Assessment of COVID-19 Pandemic

12. Antacid Market- Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies Done by the Companies in the Market, (%)
  • 12.3 Organic Developments
    • 12.3.1 Overview
  • 12.4 Inorganic Developments
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Bayer AG
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 GlaxoSmithKline plc.
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Takeda Pharmaceutical Company Limited
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Sun Pharmaceutical Industries Ltd
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Sanofi
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Boehringer Ingelheim International GmbH
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Dr. Reddy's Laboratories
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Pfizer Inc.
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 roducts and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Reckitt Benckiser Group Plc
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Procter & Gamble
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 Glossary of Terms

List Of Tables

  • Table 1. North America Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
  • Table 2. North America Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 3. North America Acid Neutralizers Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 4. North America Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 5. US Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
  • Table 6. US Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 7. US Acid Neutralizers Market, by Type- Revenue and Forecast to 2027 (USD Million)
  • Table 8. US Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 9. Canada Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
  • Table 10. Canada Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 11. Canada Acid Neutralizers Market, by Type- Revenue and Forecast to 2027 (USD Million)
  • Table 12. Canada Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 13. Mexico Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
  • Table 14. Mexico Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 15. Mexico Acid Neutralizers Market, by Type- Revenue and Forecast to 2027 (USD Million)
  • Table 16. Mexico Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 17. Europe Antacid Market, by Dosage Form- Revenue and Forecast to 2027 (USD Million)
  • Table 18. Europe Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 19. Europe Acid Neutralizers Market, by Type- Revenue and Forecast to 2027 (USD Million)
  • Table 20. Europe Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 21. Germany Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
  • Table 22. Germany Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 23. Germany Acid Neutralizers Market, by Type- Revenue and Forecast to 2027 (USD Million)
  • Table 24. Germany Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 25. UK Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
  • Table 26. UK Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 27. UK Acid Neutralizers Market, by Type- Revenue and Forecast to 2027 (USD Million)
  • Table 28. UK Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 29. France Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
  • Table 30. France Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 31. France Acid Neutralizers Market, by Type- Revenue and Forecast to 2027 (USD Million)
  • Table 32. France Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 33. Spain Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
  • Table 34. Spain Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 35. Spain Acid Neutralizers Market, by Type- Revenue and Forecast to 2027 (USD Million)
  • Table 36. Spain Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 37. Italy Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
  • Table 38. Italy Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 39. Italy Acid Neutralizers Market, by Type- Revenue and Forecast to 2027 (USD Million)
  • Table 40. Italy Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 41. Rest of Europe Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
  • Table 42. Rest of Europe Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 43. Rest of Europe Acid Neutralizers Market, by Type- Revenue and Forecast to 2027 (USD Million)
  • Table 44. Rest of Europe Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 45. Asia-Pacific: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
  • Table 46. Asia-Pacific: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 47. Asia-Pacific: Antacid Market, by Acid Neutralizers - Revenue and Forecast to 2027 (USD Million)
  • Table 48. Asia-Pacific: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 49. China: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
  • Table 50. China: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 51. China: Antacid Market, by Acid Neutralizers - Revenue and Forecast to 2027 (USD Million)
  • Table 52. China: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 53. Japan: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
  • Table 54. Japan: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 55. Japan: Antacid Market, by Acid Neutralizers - Revenue and Forecast to 2027 (USD Million)
  • Table 56. Japan: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 57. India: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
  • Table 58. India: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 59. India: Antacid Market, by Acid Neutralizers - Revenue and Forecast to 2027 (USD Million)
  • Table 60. India: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 61. South Korea: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
  • Table 62. South Korea: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 63. South Korea: Antacid Market, by Acid Neutralizers - Revenue and Forecast to 2027 (USD Million)
  • Table 64. South Korea: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 65. Australia: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
  • Table 66. Australia: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 67. Australia: Antacid Market, by Acid Neutralizers - Revenue and Forecast to 2027 (USD Million)
  • Table 68. Australia: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 69. Rest of Asia Pacific: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
  • Table 70. Rest of Asia Pacific: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 71. Rest of Asia Pacific: Antacid Market, by Acid Neutralizers - Revenue and Forecast to 2027 (USD Million)
  • Table 72. Rest of Asia Pacific: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 73. Middle East & Africa: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
  • Table 74. Middle East & Africa: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 75. Middle East & Africa: Antacid Market, by Acid Neutralizers - Revenue and Forecast to 2027 (USD Million)
  • Table 76. Middle East & Africa: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 77. Saudi Arabia: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
  • Table 78. Saudi Arabia: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 79. Saudi Arabia: Antacid Market, by Acid Neutralizers - Revenue and Forecast to 2027 (USD Million)
  • Table 80. Saudi Arabia: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 81. UAE: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
  • Table 82. UAE: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 83. UAE: Antacid Market, by Acid Neutralizers - Revenue and Forecast to 2027 (USD Million)
  • Table 84. UAE: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 85. South Africa: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
  • Table 86. South Africa: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 87. South Africa Antacid Market, by Acid Neutralizers - Revenue and Forecast to 2027 (USD Million)
  • Table 88. South Africa: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 89. Rest of Middle East and Africa: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
  • Table 90. Rest of Middle East and Africa: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 91. Rest of Middle East and Africa Antacid Market, by Acid Neutralizers - Revenue and Forecast to 2027 (USD Million)
  • Table 92. Rest of Middle East and Africa: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 93. South and Central America: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
  • Table 94. South and Central America: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 95. South and Central America: Acid Neutralizers Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 96. South and Central America: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 97. Brazil: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
  • Table 98. Brazil: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 99. Brazil: Acid Neutralizers Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 100. Brazil: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 101. Argentina: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
  • Table 102. Argentina: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 103. Argentina: Acid Neutralizers Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 104. Argentina: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 105. Rest of South and Central America: Antacid Market, by Therapeutic - Revenue and Forecast to 2027 (USD Million)
  • Table 106. Rest of South and Central America: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 107. Rest of South and Central America: Acid Neutralizers Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 108. Rest of South and Central America: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 109. Organic Developments Done By Companies
  • Table 110. Inorganic Developments Done By Companies
  • Table 111. Glossary of Terms, Antacid Market

List Of Figures

  • Figure 1. Antacid Market Segmentation
  • Figure 2. Antacid Market - By Geography
  • Figure 3. Antacid Market Overview
  • Figure 4. Liquid to Witness Rapid Growth of Antacid Market
  • Figure 5. Asia Pacific to Show Significant Growth During Forecast Period
  • Figure 6. Antacid Market, by Geography (US$ Million)
  • Figure 7. Global Antacid Market - Leading Country Markets (US$ Million)
  • Figure 8. Global Antacid Market, Industry Landscape
  • Figure 9. North America PEST Analysis
  • Figure 10. Europe PEST Analysis
  • Figure 11. Asia Pacific PEST Analysis
  • Figure 12. Middle East and Africa (MEA) PEST Analysis
  • Figure 13. South and Central America (SCAM) PEST Analysis
  • Figure 14. Antacid Market Impact Analysis of Drivers and Restraints
  • Figure 15. Global Antacid Market - Revenue Forecast And Analysis - 2019- 2027
  • Figure 16. Global Antacid Market - By Geography Forecast and Analysis - 2019- 2027
  • Figure 17. Market Positioning Of Key Players In Global Antacid Market
  • Figure 18. Antacid Market Revenue Share, by Dosage Form (2019 and 2027)
  • Figure 19. Tablet: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 20. Liquid: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 21. Others: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 22. Antacid Market Revenue Share, by Drug Class (2019 and 2027)
  • Figure 23. Proton Pump Inhibitors: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 24. H2 Antagonist: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 25. Acid Neutralizers: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 26. Magaldrate: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 27. Sucralfate: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 28. Others: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 29. Antacid Market Share, by Distribution Channel, 2019 and 2027 (%)
  • Figure 30. Hospital Pharmacy: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 31. Retail Pharmacy: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 32. Online Pharmacy: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 33. North America: Antacid Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 34. North America Antacid Market Revenue and Forecast to 2027 (USD Million)
  • Figure 35. North America: Antacid Market, by Country, 2019 & 2027 (%)
  • Figure 36. US: Antacid Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 37. Canada: Antacid Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 38. Mexico: Antacid Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 39. Europe: Antacid Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 40. Europe Antacid Market Revenue and Forecast to 2027 (USD Million)
  • Figure 41. Europe: Antacid Market, by Country, 2019 & 2027 (%)
  • Figure 42. Germany: Antacid Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 43. UK: Antacid Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 44. France: Antacid Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 45. Spain: Antacid Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 46. Italy: Antacid Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 47. Rest of Europe: Antacid Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 48. Asia-Pacific: Antacid Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 49. Asia-Pacific: Antacid Market, Revenue and Forecast to 2027 (USD Million)
  • Figure 50. Asia-Pacific: Antacid Market, by Country, 2019 & 2027 (%)
  • Figure 51. China: Antacid Market, - Revenue and Forecast to 2027 (USD Million)
  • Figure 52. Japan Antacid Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 53. India: Antacid Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 54. South Korea: Antacid Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 55. Australia: Antacid - Revenue and Forecast to 2027 (USD Million)
  • Figure 56. Rest of Asia Pacific: Antacid Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 57. Middle East & Africa: Antacid Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 58. Middle East & Africa Antacid Market -Revenue and Forecast to 2027 (USD Million)
  • Figure 59. Middle East & Africa: Antacid Market, by Country, 2019 & 2027 (%)
  • Figure 60. Saudi Arabia: Antacid Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 61. UAE: Antacid Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 62. South Africa: Antacid Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 63. Rest of Middle East and Africa: Antacid Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 64. South and Central America: Antacid Market , by Key Country - Revenue (2019) (USD Million)
  • Figure 65. South and Central America: Antacid Market, Revenue and Forecast to 2027 (USD Million)
  • Figure 66. South and Central America: Antacid Market, by Country, 2019 & 2027 (%)
  • Figure 67. Brazil: Antacid Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 68. Argentina: Antacid Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 69. Rest of South and Central America: Antacid Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 70. Impact of COVID-19 Pandemic on Antacid Market in North American Countries
  • Figure 71. Impact of COVID-19 Pandemic on Antacid Market in European Countries
  • Figure 72. Impact of COVID-19 Pandemic on Antacid Market in Asia Pacific Countries
  • Figure 73. Impact of COVID-19 Pandemic on Antacid Market in Rest of the World
  • Figure 74. Growth Strategies Done by the Companies in the Market